Reporting Manager
BIOTECHNOLOGY VALUE FUND L P
Symbol
EPIX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
14 Oct 2025, 17:30:50 UTC
Date of event
09 Oct 2025
Previous filing
07 Aug 2025

Sponsored

Quoteable Key Fact

"BIOTECHNOLOGY VALUE FUND L P disclosed 0% ownership in ESSA Pharma Inc. Common Shares (EPIX) on 09 Oct 2025."

Quick Takeaways

  • BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13D/A for ESSA Pharma Inc. Common Shares (EPIX).
  • Disclosed ownership: 0%.
  • Date of event: 09 Oct 2025.

What Changed

  • Previous schedule filing date: 07 Aug 2025.
  • Current filing was accepted on 14 Oct 2025, 17:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 0% 0 0 0 /s/ Mark N. Lampert Mark N. Lampert 0001233840